<i>shp-2</i> gene knockout upregulates CAR-driven cytotoxicity of YT NK cells

In Russia, cancer is the second leading cause of death following cardiovascular diseases. Adoptive transfer of NK cells is a promising approach to fight cancer; however, for their successful use in cancer treatment, it is necessary to ensure their robust accumulation at tumor foci, provide resistanc...

Full description

Saved in:
Bibliographic Details
Main Authors: V. G. Subrakova, S. V. Kulemzin, T. N. Belovezhets, A. N. Chikaev, N. A. Chikaev, O. A. Koval, A. A. Gorchakov, A. V. Taranin
Format: Article
Language:English
Published: Siberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and Breeders 2020-03-01
Series:Вавиловский журнал генетики и селекции
Subjects:
Online Access:https://vavilov.elpub.ru/jour/article/view/2483
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832575131293057024
author V. G. Subrakova
S. V. Kulemzin
T. N. Belovezhets
A. N. Chikaev
N. A. Chikaev
O. A. Koval
A. A. Gorchakov
A. V. Taranin
author_facet V. G. Subrakova
S. V. Kulemzin
T. N. Belovezhets
A. N. Chikaev
N. A. Chikaev
O. A. Koval
A. A. Gorchakov
A. V. Taranin
author_sort V. G. Subrakova
collection DOAJ
description In Russia, cancer is the second leading cause of death following cardiovascular diseases. Adoptive transfer of NK cells is a promising approach to fight cancer; however, for their successful use in cancer treatment, it is necessary to ensure their robust accumulation at tumor foci, provide resistance to the immunosuppressive tumor microenvironment, and to engineer them with higher cytotoxic activity. NK lymphocytes are known to kill cancer cells expressing a number of stress ligands; and the balance of signals from inhibitory and activating receptors on the surface of the NK cell determines whether a cytotoxic reaction is triggered. We hypothesized that stronger cytotoxicity of NK cells could be achieved via gene editing aimed at enhancing the activating signaling cascades and/or weakening the inhibitory ones, thereby shifting the balance of signals towards NK cell activation and target cell lysis. Here, we took advantage of the CRISPR/Cas9 system to introduce mutations in the coding sequence of the shp-2 (PTPN11) gene encoding the signaling molecule of inhibitory pathways in NK cells. These shp-2 knock-out NK cells were additionally transduced to express a chimeric antigen receptor (CAR) that selectively recognized the antigen of interest on the target cell surface and generated an activating signal. We demonstrate that the combination of shp-2 gene knockout and CAR expression increases the cytotoxicity of effector NK-like YT cells against human prostate cancer cell line Du-145 with ectopic expression of PSMA protein, which is specifically targeted by the CAR.
format Article
id doaj-art-00ec533aee1649809b97f8a9cd4bceba
institution Kabale University
issn 2500-3259
language English
publishDate 2020-03-01
publisher Siberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and Breeders
record_format Article
series Вавиловский журнал генетики и селекции
spelling doaj-art-00ec533aee1649809b97f8a9cd4bceba2025-02-01T09:58:08ZengSiberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and BreedersВавиловский журнал генетики и селекции2500-32592020-03-01241808610.18699/VJ20.5981025<i>shp-2</i> gene knockout upregulates CAR-driven cytotoxicity of YT NK cellsV. G. Subrakova0S. V. Kulemzin1T. N. Belovezhets2A. N. Chikaev3N. A. Chikaev4O. A. Koval5A. A. Gorchakov6A. V. Taranin7Institute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences; Novosibirsk State UniversityInstitute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of SciencesInstitute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences; Novosibirsk State UniversityInstitute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of SciencesInstitute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of SciencesInstitute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of SciencesInstitute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences; Novosibirsk State UniversityInstitute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences; Novosibirsk State UniversityIn Russia, cancer is the second leading cause of death following cardiovascular diseases. Adoptive transfer of NK cells is a promising approach to fight cancer; however, for their successful use in cancer treatment, it is necessary to ensure their robust accumulation at tumor foci, provide resistance to the immunosuppressive tumor microenvironment, and to engineer them with higher cytotoxic activity. NK lymphocytes are known to kill cancer cells expressing a number of stress ligands; and the balance of signals from inhibitory and activating receptors on the surface of the NK cell determines whether a cytotoxic reaction is triggered. We hypothesized that stronger cytotoxicity of NK cells could be achieved via gene editing aimed at enhancing the activating signaling cascades and/or weakening the inhibitory ones, thereby shifting the balance of signals towards NK cell activation and target cell lysis. Here, we took advantage of the CRISPR/Cas9 system to introduce mutations in the coding sequence of the shp-2 (PTPN11) gene encoding the signaling molecule of inhibitory pathways in NK cells. These shp-2 knock-out NK cells were additionally transduced to express a chimeric antigen receptor (CAR) that selectively recognized the antigen of interest on the target cell surface and generated an activating signal. We demonstrate that the combination of shp-2 gene knockout and CAR expression increases the cytotoxicity of effector NK-like YT cells against human prostate cancer cell line Du-145 with ectopic expression of PSMA protein, which is specifically targeted by the CAR.https://vavilov.elpub.ru/jour/article/view/2483nk cellscrispr/cas9car-nkshp-2
spellingShingle V. G. Subrakova
S. V. Kulemzin
T. N. Belovezhets
A. N. Chikaev
N. A. Chikaev
O. A. Koval
A. A. Gorchakov
A. V. Taranin
<i>shp-2</i> gene knockout upregulates CAR-driven cytotoxicity of YT NK cells
Вавиловский журнал генетики и селекции
nk cells
crispr/cas9
car-nk
shp-2
title <i>shp-2</i> gene knockout upregulates CAR-driven cytotoxicity of YT NK cells
title_full <i>shp-2</i> gene knockout upregulates CAR-driven cytotoxicity of YT NK cells
title_fullStr <i>shp-2</i> gene knockout upregulates CAR-driven cytotoxicity of YT NK cells
title_full_unstemmed <i>shp-2</i> gene knockout upregulates CAR-driven cytotoxicity of YT NK cells
title_short <i>shp-2</i> gene knockout upregulates CAR-driven cytotoxicity of YT NK cells
title_sort i shp 2 i gene knockout upregulates car driven cytotoxicity of yt nk cells
topic nk cells
crispr/cas9
car-nk
shp-2
url https://vavilov.elpub.ru/jour/article/view/2483
work_keys_str_mv AT vgsubrakova ishp2igeneknockoutupregulatescardrivencytotoxicityofytnkcells
AT svkulemzin ishp2igeneknockoutupregulatescardrivencytotoxicityofytnkcells
AT tnbelovezhets ishp2igeneknockoutupregulatescardrivencytotoxicityofytnkcells
AT anchikaev ishp2igeneknockoutupregulatescardrivencytotoxicityofytnkcells
AT nachikaev ishp2igeneknockoutupregulatescardrivencytotoxicityofytnkcells
AT oakoval ishp2igeneknockoutupregulatescardrivencytotoxicityofytnkcells
AT aagorchakov ishp2igeneknockoutupregulatescardrivencytotoxicityofytnkcells
AT avtaranin ishp2igeneknockoutupregulatescardrivencytotoxicityofytnkcells